Cargando…

SV40: A Human Pathogen?

Over the past eight years an increasing number of investigators have found SV40 genomic sequences in a variety of human samples, both malignant and normal. Tumor types recurrently reported as SV40-positive include choroid plexus neoplasms, ependymomas, osteosarcomas, and mesotheliomas. Nonetheless,...

Descripción completa

Detalles Bibliográficos
Autor principal: Garcea, Robert L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851613/
https://www.ncbi.nlm.nih.gov/pubmed/11790879
http://dx.doi.org/10.1155/2001/515039
_version_ 1782294312346714112
author Garcea, Robert L.
author_facet Garcea, Robert L.
author_sort Garcea, Robert L.
collection PubMed
description Over the past eight years an increasing number of investigators have found SV40 genomic sequences in a variety of human samples, both malignant and normal. Tumor types recurrently reported as SV40-positive include choroid plexus neoplasms, ependymomas, osteosarcomas, and mesotheliomas. Nonetheless, considerable skepticism that SV40 is a human pathogen still prevails. More constructively, the study of SV40 in humans has renewed interest in the related BK and JC viruses and their role in human disease. New questions now must be addressed. In particular, seroepidemiologic studies utilizing reagents that distinguish SV40, BKV, and JCV immune responses would be a logical next step for independently assessing viral prevalence. Also, prospective studies of select patient groups using optimized detection methods might determine whether SV40 is associated with human oncogenesis in particular circumstances. The importance of such research is underscored by the potential to prevent human polyomavirus infections, and possible associated malignancy, through immunization of high risk populations.
format Online
Article
Text
id pubmed-3851613
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher IOS Press
record_format MEDLINE/PubMed
spelling pubmed-38516132013-12-22 SV40: A Human Pathogen? Garcea, Robert L. Dis Markers Other Over the past eight years an increasing number of investigators have found SV40 genomic sequences in a variety of human samples, both malignant and normal. Tumor types recurrently reported as SV40-positive include choroid plexus neoplasms, ependymomas, osteosarcomas, and mesotheliomas. Nonetheless, considerable skepticism that SV40 is a human pathogen still prevails. More constructively, the study of SV40 in humans has renewed interest in the related BK and JC viruses and their role in human disease. New questions now must be addressed. In particular, seroepidemiologic studies utilizing reagents that distinguish SV40, BKV, and JCV immune responses would be a logical next step for independently assessing viral prevalence. Also, prospective studies of select patient groups using optimized detection methods might determine whether SV40 is associated with human oncogenesis in particular circumstances. The importance of such research is underscored by the potential to prevent human polyomavirus infections, and possible associated malignancy, through immunization of high risk populations. IOS Press 2001 2002-06-07 /pmc/articles/PMC3851613/ /pubmed/11790879 http://dx.doi.org/10.1155/2001/515039 Text en Copyright © 2001 Hindawi Publishing Corporation.
spellingShingle Other
Garcea, Robert L.
SV40: A Human Pathogen?
title SV40: A Human Pathogen?
title_full SV40: A Human Pathogen?
title_fullStr SV40: A Human Pathogen?
title_full_unstemmed SV40: A Human Pathogen?
title_short SV40: A Human Pathogen?
title_sort sv40: a human pathogen?
topic Other
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851613/
https://www.ncbi.nlm.nih.gov/pubmed/11790879
http://dx.doi.org/10.1155/2001/515039
work_keys_str_mv AT garcearobertl sv40ahumanpathogen